Product Information
Dehydrocavidine is a heparin-induced thrombocytopenia (HIT) treatment that belongs to the group of corydalis alkaloids. It is a competitive inhibitor of P-glycoprotein and has been shown to inhibit the proliferation of carcinoma cell lines. Dehydrocavidine has been studied as a potential anti-cancer drug for squamous cell carcinoma and also has been shown to be an effective treatment for hepatitis B. Dehydrocavidine is used in the treatment of HIT, but it does not have any significant toxicity studies or long-term side effects. This drug inhibits polymerase chain reaction by binding to DNA polymerase at the 3’ end. It also has biological properties such as an ability to induce apoptosis in human hepatocarcinoma cells, which may be due to its ability to inhibit protein synthesis or activate tumor suppressor genes such as p53.
Chemical properties
Technical inquiry about: 3D-FD65683 Dehydrocavidine
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
